Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen Molina Healthcare Inc stake
total: 670
Viking Global Investors MOH trades
- Total transactions:
- 24
- New positions:
- 4
- Sold out:
- 4
- Added:
- 7
- Reduced:
- 9
- Held since:
- 2025 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2025 Q3
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any Molina Healthcare Inc (MOH) shares. To date, the estimated cost basis is nearly $297.9 for "buy" trades and estimated average "sell" price is $297.9. Viking Global Investors first purchased MOH in 2014 Q3, initially acquiring about 1.18M shares. Ole Andreas Halvorsen later completely sold out the position and invested in Molina Healthcare Inc again in 2025 Q2. Since the initial investment in Molina Healthcare Inc (MOH), Viking Global Investors has made 23 more transactions.
When did Ole Andreas Halvorsen sell Molina Healthcare Inc (MOH)?
Ole Andreas Halvorsen sold off the entire Molina Healthcare Inc (MOH) position in 2025 Q3.
When did Ole Andreas Halvorsen buy Molina Healthcare Inc (MOH)?
Ole Andreas Halvorsen first invested in Molina Healthcare Inc (MOH) in 2014 Q3 at the reported quarter-end price of $42.30 per share.
What's the cost basis of Viking Global Investors's MOH stake?
The estimated cost basis for Molina Healthcare Inc (MOH) stake is around $297.90 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $297.90
- Weighted AVG sell price:
- $297.90
Ole Andreas Halvorsen's historical trades in Molina Healthcare Inc
24 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$297.90
|
|
-100% (-267,421)
|
-0.23%
|
|
2025 Q2
|
0.23%
|
267,421
|
$297.90
|
$79,664,716
|
new
|
+0.23%
|
|
2023 Q2
|
0.00%
|
0
|
$267.49
|
|
-100% (-594,553)
|
-0.75%
|
|
2023 Q1
|
0.75%
|
594,553
|
$267.49
|
$159,036,982
|
+1.08% (+6,345)
|
+0.01%
|
|
2022 Q4
|
0.97%
|
588,208
|
$330.22
|
$194,238,046
|
+44.64% (+181,537)
|
+0.3%
|
|
2022 Q3
|
0.62%
|
406,671
|
$329.84
|
$134,136,000
|
-14.41% (-68,487)
|
-0.1%
|
|
2022 Q2
|
0.61%
|
475,158
|
$279.61
|
$132,859,000
|
+13.98% (+58,275)
|
+0.07%
|
|
2022 Q1
|
0.56%
|
416,883
|
$333.59
|
$139,068,000
|
-6.88% (-30,803)
|
-0.03%
|
|
2021 Q4
|
0.41%
|
447,686
|
$318.08
|
$142,400,000
|
-52.13% (-487,540)
|
-0.43%
|
|
2021 Q3
|
0.70%
|
935,226
|
$271.31
|
$253,736,000
|
-3.92% (-38,130)
|
-0.03%
|
|
2021 Q2
|
0.75%
|
$253.06
|
-32.11% (-460,397)
|
|||
|
2021 Q1
|
1.00%
|
$233.76
|
+40.19% (+411,014)
|
|||
|
2020 Q4
|
0.60%
|
$212.68
|
-15.97% (-194,320)
|
|||
|
2020 Q3
|
0.80%
|
$183.04
|
+20.06% (+203,391)
|
|||
|
2020 Q2
|
0.78%
|
$177.98
|
-25.75% (-351,584)
|
|||
|
2020 Q1
|
0.99%
|
$139.71
|
-40.95% (-946,671)
|
|||
|
2019 Q4
|
1.47%
|
$135.69
|
+57.27% (+841,862)
|
|||
|
2019 Q3
|
0.84%
|
$109.72
|
new
|
|||
|
2018 Q1
|
0.00%
|
$76.68
|
-100% (-1,672,822)
|
|||
|
2017 Q4
|
0.79%
|
$76.68
|
-14.09% (-274,385)
|
|||
|
2017 Q3
|
0.87%
|
$68.76
|
+31.85% (+470,375)
|
|||
|
2017 Q2
|
0.69%
|
$69.18
|
new
|
|||
|
2014 Q4
|
0.00%
|
$42.30
|
-100% (-1,183,932)
|
|||
|
2014 Q3
|
0.20%
|
$42.30
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.